Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,785 | Dovepress* | 6,309+ | 1,355 | 7,664 | |
PubMed Central* | 476 | 223 | 699 | ||
Totals | 6,785 | 1,578 | 8,363 | ||
*Since 19 September 2018 |
View citations on PubMed Central and Google Scholar